Susan Barlin, CEO of FHPI, said the California-based company has experienced strong volume orders during the height of the pandemic for the Philippine market.
Barlin said the company is targeting P500 million sales growth target next year. This would be boosted with the opening of marketing operations in 20 countries next year.
According to Barlin, the growth drivers would be its new product Imuregen, which she described as an immunity booster that works right from the DNA level.
“Imuregen will hit the markets soon,” said Barlin.
“With immune system being the key words right now and with no source of product like ours — this will skyrocket next year,” he said.
At a time when lifestyle diseases and a global pandemic threatens humans, Barlin said IMUREGEN is touted as a way to boost the immune system of both the present and future generations. The possibility of starting healthy living from the core of human physiology (DNA) has been a pleasant surprise for many.
While vitamins and antioxidants are indeed beneficial for health, a product that targets the body’s DNA would be more effective.
“In a world of evolving medical technology, the immune system is often overlooked in favor of corrective methods rather than preventive ones,” she said.
“Forever Healthy LLC is all set to revolutionize how humans protect themselves from the onslaught of viruses and pathogens. Previously sold only in Europe, the immune system booster will now be available in the USA,” she added.